Summary & Overview
HCPCS E2513: EMG Sensor Accessory for Speech-Generating Device
HCPCS Level II code E2513 designates an electromyographic (EMG) sensor accessory for speech-generating devices, used to capture muscle electrical activity to control or augment augmentative and alternative communication (AAC) systems. Nationally, this code matters as assistive-technology accessories increasingly support communication for people with neuromuscular and neurogenic conditions, influencing durable medical equipment coverage and interoperability between AAC components. Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find a concise clinical and billing context for E2513, including the device function, typical sites of service (home, outpatient clinics, rehabilitation settings), and the role of EMG sensors within AAC solutions. The publication summarizes payer coverage patterns, common modifier usage, and where benchmarking and policy updates affect reimbursement and prior authorization practices. It also outlines clinical scenarios where an EMG sensor accessory is deployed and highlights administrative considerations for claims submission. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code E2513 describes an accessory for a speech generating device: electromyographic sensor. This accessory captures electromyographic (EMG) signals to enable or enhance speech-generating device input for individuals with communication impairments.
-
Service type: Assistive technology accessory for augmentative and alternative communication (AAC)
-
Typical site of service: Home, outpatient clinic, rehabilitation facility, or other community settings where speech-generating devices are used
Clinical & Coding Specifications
Clinical Context
A 12-year-old nonverbal child with cerebral palsy uses a dedicated speech-generating device (SGD) to communicate. The child demonstrates orofacial motor limitations and inconsistent voluntary speech motor control. An interdisciplinary clinic visit with a speech-language pathologist (SLP) and a durable medical equipment (DME) provider is scheduled to evaluate assistive technology options. During the visit the SLP performs a trial of an electromyographic (EMG) sensor accessory to detect small muscle activations (e.g., forehead, cheek, or neck muscles) that the child can reliably control. The EMG sensor is connected to the SGD to map detected signals to vocabulary selection or single-switch activation.
The clinical workflow includes: pre-visit review of prior assistive technology evaluations; in-clinic functional assessment and trials of the E2513 EMG sensor by the SLP; configuration of sensor sensitivity and signal-to-action mapping; caregiver training on placement, maintenance, and troubleshooting; documentation of objective response and plan for procurement if the accessory improves communication access. Typical site of service is an outpatient rehabilitation clinic, specialized assistive technology center, or pediatric therapy clinic. The patient scenario represents use of an accessory to enable or augment access to an SGD when conventional touch or switch access is not feasible.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 |